Interakce mezi anti-VEGF léčbou a protinádorovou imunitou jako potenciální léčebná strategie kolorektálního karcinomu
dc.contributor.author | Buka D. | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Škrobánek Pavel | cs |
dc.contributor.author | Buchler Tomáš | cs |
dc.contributor.author | Melichar Bohuslav | cs |
dc.date.accessioned | 2020-06-08T09:45:59Z | |
dc.date.available | 02-36-2020 | en |
dc.date.available | 2020-06-08T09:45:59Z | |
dc.date.issued | 2019 | cs |
dc.date.updated | 05-39-2020 | en |
dc.format.extent | 4 | cs |
dc.identifier.issn | 1211-4286 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/156240 | |
dc.language.iso | eng | cs |
dc.publisher.city | Hradec Králové | cs |
dc.relation.ispartof | Acta Medica 2019 | en |
dc.relation.ispartofseries | 0 | cs |
dc.relation.uri | https://actamedica.lfhk.cuni.cz/62/3/0127/ | cs |
dc.subject | vascular endothelial growth inhibition | cs |
dc.subject | antitumor immunity | cs |
dc.subject | colorectal cancer | cs |
dc.title | Interakce mezi anti-VEGF léčbou a protinádorovou imunitou jako potenciální léčebná strategie kolorektálního karcinomu | en |
dc.title | Interactions between Anti-VEGF Therapy and Antitumor Immunity as a Ptentional Therapeutic Strategy in Colorectal Cancer | cs |
local.citation.epage | 127-130 | cs |
local.citation.spage | 127-130 | cs |
local.identifier.publikace | 6948 | |
local.relation.issue | 1 | cs |